本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Compass Therapeutics, Inc.

1.82
-0.0350-1.89%
成交量:135.27萬
成交額:248.95萬
市值:3.27億
市盈率:-4.49
高:1.90
開:1.87
低:1.81
收:1.85
52周最高:6.88
52周最低:1.61
股本:1.80億
流通股本:1.32億
量比:0.51
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-0.4039
每股收益(LYR):-0.4216
淨資產收益率:-56.66%
總資產收益率:-33.03%
市淨率:1.97
市盈率(LYR):-4.30

資料載入中...

2021/04/19

重要事件披露

8-K - Current report
2021/03/05

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/01/14

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/17

重要事件披露

8-K - Current report
2020/11/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/23

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/15

重要事件披露

8-K - Current report
2020/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/31

重要事件披露

8-K/A [Amend] - Current report
2020/07/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership